Altay Therapeutics, Inc.
Undisclosed of $15.7M

Undisclosed of $15.7M
Undisclosed of $16.5M
Undisclosed of $11.4M
Undisclosed of $7.8M
IPO of $446M
Undisclosed of $10.0M
Undisclosed of $9.1M
Undisclosed of $5.5M
FDA goal date for apitegromab (BLA)
Change in directors or officers
Change in directors or officers
Change in directors or officers
Change in directors or officers
Change in directors or officers